HAVA · Harvard Ave Acquisition Corp
$10.14
+0.00 (+0.00%)
At close · Jul 21
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of March 31, 2026, the Company has a related party receivable of $867,711 and working capital of $473,263. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.”View the 10-Q filed May 8, 2026
Market Cap
$209.83M
Shares
20.69M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.14
Open$10.14
Day$10.14–10.14
52W$9.87–10.14
Avg vol 30d3K
Short int3K · 0.0% float · 1.0d
Short vol28%
DataDec 2025–Jul 2026
Filing10-Q · May 8
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 17.1 · elevated
Equity put/call 0.65
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+0%
above
RSI (14)
75
overbought
MACD trend
Positive
52-week position
100%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+1%
trailing
YTD return
+2%
this year
Relative strength
−6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+75% holders QoQ · +15 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -0.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
35 holders — 13F breadth
Squeeze score
21
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
2%
annualized · 1-yr
Max drawdown
−1%
past year
ATR
0.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+0%
Bullish
RSI (14)
75
Bearish
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+75% holders QoQ · +15 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -0.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
35 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $10
Now $10 · 100%
52-wk high $10
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HAVA
this stock
Harvard Ave Acquisition Corp
|
$209.83M | +2.1% | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | +0.0% | — | 100.2 | — |
|
XXI
Twenty One Capital, Inc.
|
$3.27B | -43.8% | — | — | 0.7% |
|
CCXI
Churchill Capital Corp XI
|
$826.03M | — | — | — | 0.9% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$642.10M | +1.8% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HAVA | +0.2% | +0.2% | +1.4% | +0.4% | +2.1% |
| SPY | -0.5% | +0.5% | +7.6% | +0.2% | +9.7% |
| vs SPY | +0.7% | -0.3% | -6.2% | +0.2% | -7.6% |
Key facts
CIK
2042460
CUSIP
G4330A103